Citigroup analyst Steven Enders maintains Asana (NYSE:ASAN) with a Neutral and raises the price target from $23 to $24.
With Meaningful Upside, This Cancer Stock Earns Analyst Upgrade
BMO Capital Markets upgraded Seagen Inc (NASDAQ:SGEN) from Market Perform to Outperform with a price target of $178 from $177, saying the…